Consun Pharmaceutical Group Limited
HKEX:1681.HK
Overview | Financials
Company Name | Consun Pharmaceutical Group Limited |
Symbol | 1681.HK |
Currency | HKD |
Price | 8.61 |
Market Cap | 7,145,645,640 |
Dividend Yield | 6.8% |
52-week-range | 4.38 - 8.88 |
Industry | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Ms. Qian Li |
Website | https://www.chinaconsun.com |
An error occurred while fetching data.
About Consun Pharmaceutical Group Limited
Consun Pharmaceutical Group Limited, an investment holding company, researches and develops, manufactures, and sells Chinese medicines and medical contrast medium products in the People's Republic of China. The company operates through two segments, Consun Pharmaceutical and Yulin Pharmaceutical. It offers uremic clearance granule to treat chronic kidney diseases; Yishen Huashi
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD